---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-193726"
form_type: "8-K"
ticker: "PLRX"
cik: "0001746473"
company_name: "PLIANT THERAPEUTICS, INC."
filed_at: "2022-07-14T23:59:59+00:00"
generated_at: "2026-06-24T15:16:54.526997+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pliant Therapeutics raises ~$200M in public offering, reports preliminary cash of $163.6M

## Summary
- Preliminary cash, cash equivalents and short-term investments of $163.6M as of June 30, 2022.
- Public offering of 10.8M shares at $18.50/share; gross proceeds ~$200M, up to $230M with overallotment.
- Underwriters granted 30-day option to purchase up to 1.6M additional shares at same price.
- Offering expected to close July 15, 2022.
- Underwriting agreement with J.P. Morgan and Cowen.

## SEC filing metadata
- accession: 0001193125-22-193726
- form_type: 8-K
- ticker: PLRX
- cik: 0001746473
- company_name: PLIANT THERAPEUTICS, INC.
- filed_at: 2022-07-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1746473/000119312522193726/0001193125-22-193726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1746473/000119312522193726/d326023d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-193726
- JSON: https://secwatch.observer/filing/0001193125-22-193726.json
- Plain text: https://secwatch.observer/filing/0001193125-22-193726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.